SCHEMBL5202612

SCHEMBL5202612

Cc1ccc(-n2ncc(N=O)c2N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 13/20 0.50
ALDH1A1 P00352 7/20 0.50
NPC1 O15118 10/20 0.49
XDH P47989 1/20 0.44
SMN1; SMN2 Q16637 7/20 0.44
MAPT P10636 4/20 0.44
HTT P42858 2/20 0.44
XBP1 P17861 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
KMT2A Q03164 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5273697 0.83 RAB9A (0.49) RAB9AALDH1A1NPC1SMN1; SMN2MAPT
SCHEMBL2119714 0.83 RAB9A (0.54) RAB9AALDH1A1NPC1SMN1; SMN2KMT2A
SCHEMBL5274776 0.83 MAPK14 (0.53) RAB9AALDH1A1NPC1XDHSMN1; SMN2
Hydrochloric Acid SCHEMBL5405647 0.81 MAPK14 (0.52) RAB9AALDH1A1NPC1XDHSMN1; SMN2
Hydrochloric Acid SCHEMBL5414203 0.81 NPBWR1 (0.44) ALDH1A1SMN1; SMN2NPSR1LMNAPKM
Hydrochloric Acid SCHEMBL11094598 0.81 RAB9A (0.53) RAB9AALDH1A1NPC1SMN1; SMN2KMT2A
SCHEMBL3251404 0.77 RAB9A (0.56) RAB9AALDH1A1NPC1XDHSMN1; SMN2
Hydrochloric Acid SCHEMBL5413922 0.75 RAB9A (0.54) RAB9AALDH1A1NPC1XDHSMN1; SMN2
SCHEMBL10767724 0.72 RAB9A (0.50) RAB9AALDH1A1NPC1XDHSMN1; SMN2
SCHEMBL1692019 0.72 RIPK2 (0.71) RAB9AALDH1A1NPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1408025-B1 3,3-DIALKOXY-2-HYDROXYIMINOPROPIONITRILES, PROCESS FOR PREPARATION THEREOF AND PROCESS OF PREPARING 5-AMINO -4-NITROSOPYRAZOLES OR SALTS THEREOF BY THE USE OF THE SAME UBE INDUSTRIES (JP) 2007-11-21 EP disclosed
EP-1817379-A2 PYRAZOLE AZOMETHINES AND COLORANTS CONTAINING THESE COMPOUNDS The Procter and Gamble Company (US) 2007-08-15 EP disclosed
US-7256304-B2 Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2007-08-14 US disclosed
US-7227032-B2 3,3-dialkoxy-2-hydroxyiminopropionitriles, process for preparation thereof and process of preparing 5-amino-4-nitrosopyrazoles or salts thereof by the use of the same UBE INDUSTRIES, LTD. (JP) 2007-06-05 US disclosed
US-20070033742-A1 Pyrazole azomethines and colorants containing these compounds PROCTER & GAMBLE COMPANY, THE 2007-02-15 US disclosed
WO-2006060564-A2 PYRAZOLE AZOMETHINES AND COLORANTS CONTAINING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2006-06-08 WO disclosed
US-20050096472-A1 Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2005-05-05 US disclosed
EP-1475369-A1 PROCESS FOR PRODUCING 3-UNSUBSTITUTED 5-AMINO-4-NITROSOPYRAZOLE COMPOUND, AND 2-HYDROXYIMINO-3-OXOPROPIONITRILE, 3-HYDRAZONO-2-HYDROXYIMINOPROPIONITRILE COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2004-11-10 EP disclosed
US-20040116732-A1 3,3-Dialkoxy-2-hydroxyiminopropionitriles, process for preparation thereof and process of preparing 5-amino-4-nitrosopyrazoles or salts thereof by the use of the same UBE INDUSTRIES, LTD. (JP) 2004-06-17 US disclosed
EP-1408025-A1 3,3-DIALKOXY-2-HYDROXYIMINOPROPIONITRILES, PROCESS FOR PREPARATION THEREOF AND PROCESS OF PREPARING 5-AMINO -4-NITROSOPYRAZOLES OR SALTS THEREOF BY THE USE OF THE SAME Ube Industries, Ltd. (JP) 2004-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070033742-A1 Pyrazole azomethines and colorants containing these compounds KRT18, NOX5, TUBB3 RAB9A 3691/4885ALDH1A1 193/4885NPC1 4751/4885
US-20050096472-A1 Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these CYP1A1, CYP2E1, NOS3 RAB9A 3553/4885ALDH1A1 182/4885NPC1 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.